Answers are grounded in this paper and cite their sources.
NMR spectroscopy is increasingly used for biomarker analysis in blood, yet its application to alternative biological matrices remains limited. Follicular fluid (FF), which surrounds the developing oocyte, is an underexplored sample type in this context. The role of inflammation in human reproduction is not fully understood. Here, we evaluated the clinical utility of the NMR-derived composite biomarkers GlycA and GlycB measured in FF as proxies for local ovarian inflammation and assessed their association with reproductive outcomes in modified natural cycle (MNC)-IVF. This single-center retrospective cohort study included FF of 367 cycles from 204 patients undergoing MNC-IVF and 20 matching plasma samples. A total of 235 embryos were transferred resulting in 66 positive pregnancy tests and 37 live births. GlycA (283 ± 52 vs. 361 ± 50 μmol/l, p <0 .001) but not GlycB levels in FF were consistently lower than in plasma. GlycA (r = 0.408, p=<0.001) and weaker GlycB (r = 0.230, p < 0.001) in FF correlated positively with BMI, but not with age and duration of subfertility. Interestingly, a higher inflammatory load in follicular fluid, as reflected by GlycA but not GlycB, was associated with decreased odds of oocytes developing into top quality embryos (odds ratio [OR] 0.71, 95% confidence interval [CI] [0.56−0.89], p = 0.004), positive pregnancy tests (OR 0.73 [0.56−0.95], p = 0.017), ongoing pregnancies (OR 0.69 [0.52−0.92], p = 0.013) and live births (OR 0.49 [0.29−0.84], p = 0.01). Specifically the NMR-based biomarker GlycA in follicular fluid has diagnostic utility to determine local ovarian inflammation with relevance for key MNC-IVF reproductive outcomes.
No takes yet. Share an insight, caveat, or question.
Hofsink et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: